These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26826394)

  • 1. D-dimer as a potential biomarker for the progression of COPD.
    Zhang M; Zhang J; Zhang Q; Yang X; Shan H; Ming Z; Chen H; Liu Y; Yin J; Li Y
    Clin Chim Acta; 2016 Apr; 455():55-9. PubMed ID: 26826394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer levels in stable COPD patients: a case-control study.
    Silva DR; Coelho AC; Gazzana MB; Menna Barreto SS; Knorst MM
    COPD; 2012 Aug; 9(4):426-31. PubMed ID: 22612665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Liu BH; Sun MX; Zhou N; Li YP; Wang MZ; Yu J; Zhou HS
    J Biol Regul Homeost Agents; 2016; 30(3):839-845. PubMed ID: 27655508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation.
    Fruchter O; Yigla M; Kramer MR
    Am J Med Sci; 2015 Jan; 349(1):29-35. PubMed ID: 25233043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients.
    Zhang M; Li Y; Yang X; Shan H; Zhang Q; Ming Z; Xie Y; Chen H; Liu Y; Zhang J
    Inflammation; 2016 Apr; 39(2):625-31. PubMed ID: 26613760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean platelet volume is elevated in exacerbated and convalescent COPD patients.
    Zhang M; Li Y; Zhang J; Zhang Q; Yang X; Shan H; Xie Y; Jin Q; Feng X
    Clin Chim Acta; 2015 Dec; 451(Pt B):227-31. PubMed ID: 26436484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
    Wang RT; Li JY; Cao ZG; Li Y
    Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
    Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
    Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein levels in stable COPD patients: a case-control study.
    Silva DR; Gazzana MB; Knorst MM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
    Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
    Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
    Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
    Lung; 2008; 186(6):403-9. PubMed ID: 18807087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
    Fowkes FG; Anandan CL; Lee AJ; Smith FB; Tzoulaki I; Rumley A; Powell JT; Lowe GD
    J Vasc Surg; 2006 Mar; 43(3):474-80. PubMed ID: 16520158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between nutritional status and oxidative stress markers, pulmonary function in patients with stable chronic obstructive pulmonary disease].
    Jiang XL; Zhong P; Huang CL; He F; Fan XM; Chen XR
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):40-45. PubMed ID: 28100361
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous hydrogen sulfide in patients with COPD.
    Chen YH; Yao WZ; Geng B; Ding YL; Lu M; Zhao MW; Tang CS
    Chest; 2005 Nov; 128(5):3205-11. PubMed ID: 16304263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
    Liu H; Xu JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and clinical significance of vascular cell adhesion molecules-1 in chronic obstructive pulmonary disease].
    Pan L; Yang YH; Dong DQ; Liu XC
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):291-3. PubMed ID: 18846968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.